🔎 Trials Near Me

Home › Follicular Lymphoma › Minnesota › Rochester

Follicular Lymphoma clinical trials in Rochester, MN

10 studies for Follicular Lymphoma are looking for participants at sites in and around Rochester (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

RecruitingPhase 1/2
  • Research Site, Rochester
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT06542250

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

RecruitingPhase 1/2
  • Mayo Clinic Rochester, Rochester
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT05006716

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

RecruitingPhase 1
  • Mayo Clinic - Rochester, Rochester
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07226843

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

RecruitingPhase 1
  • Mayo Clinic - Rochester, Rochester
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07101328

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

RecruitingPhase 2
  • Research Site, Rochester
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT06526793

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

RecruitingPhase 3
  • Mayo Clinic - Rochester, Rochester
Ages 18 and older · All sexes · Updated Aug 28, 2026 · NCT05303519

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

RecruitingPhase 1/2
  • Mayo Clinic, Clinical Trials Referral Office, Rochester
Ages 13 to 90 · All sexes · Updated Aug 6, 2026 · NCT06533579

Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas

RecruitingPhase 1/2
  • Mayo Clinic in Rochester, Rochester
Ages 18 and older · All sexes · Updated Jun 24, 2026 · NCT07468136

A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma

RecruitingPhase 1/2
  • Mayo Clinic, Rochester
Ages 18 and older · All sexes · Updated Jan 30, 2026 · NCT04669171

Q702 for the Treatment of Patients With Hematologic Malignancies

RecruitingPhase 1
  • Mayo Clinic in Rochester, Rochester
Ages 18 and older · All sexes · Updated Oct 10, 2025 · NCT06712810

Follicular Lymphoma trials in other cities

Other studies in Rochester

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.